Literature DB >> 24605219

Prolonged pleural catheters in the management of pleural effusions due to breast cancer.

Ozkan Demirhan1, Cetin Ordu2, Alper Toker3.   

Abstract

BACKGROUND: Breast cancer is the second most common etiologic cause in malignant pleural effusions (MPE). The aim of this study was to investigate the efficacy of long term pleural catheters in inducing self sclerosis in pleural effusions of breast cancer patients.
METHODS: In this study, 26 patients with breast cancer relapleural effusions that occurred between January 2011 and July 2013, who were considered not to undergo any other treatments and managed with prolonged pleural catheters (Jackson-Pratt silicone flat drain), were retrospectively analyzed. Thirty pleural catheters were inserted in 26 patients. All patients were female, mean age was 52 (range, 37-66) years old. Drainage over 1,500 mL per day was not allowed in order to avoid a lung edema. The catheters were removed in patients who had restoration of lung expansion and drainage under 50 mL/day.
RESULTS: The histologic subtypes in pleural effusions were invasive ductal carcinoma in 18 patients, ductal carcinoma in situ in 4, invasive lobular carcinoma in 2, tubular carcinoma in 1, and medullary carcinoma in 1. Three of the 26 patients underwent bilateral catheter insertion, and one patient underwent a reinsertion of the catheter into the same hemithorax due to a recurrence. The catheters were retained for a mean period of 18 days (range, 11-38 days). In one patient with invasive ductal carcinoma and paramalignant pleural effusion (PMPE) (3.8%), a recurrent pleural effusion was seen 34 days after removal of the catheter. There were no complications. One patient died while the catheter was in place.
CONCLUSIONS: Prolonged catheters for the management of pleural effusions in selected patients have become more popular than other treatment alternatives due to a shorter length of stay and lower costs. We recommend the use of Jackson Pratt (JP) silicone flat drains which in our opinion provide effective pleurodesis in addition to easy application in recurrent effusions caused by breast cancer.

Entities:  

Keywords:  Breast cancer; pleural effusion; pleurodesis; prolonged pleural catheter

Year:  2014        PMID: 24605219      PMCID: PMC3944175          DOI: 10.3978/j.issn.2072-1439.2013.12.38

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  25 in total

1.  Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions.

Authors:  J E Heffner; P J Nietert; C Barbieri
Journal:  Chest       Date:  2000-01       Impact factor: 9.410

2.  Pleuroperitoneal shunting for intractable pleural effusions.

Authors:  R B Ponn; J Blancaflor; R S D'Agostino; M E Kiernan; A L Toole; H Stern
Journal:  Ann Thorac Surg       Date:  1991-04       Impact factor: 4.330

Review 3.  [Management of malignant pleural effusions].

Authors:  R Loddenkemper
Journal:  Pneumologie       Date:  2005-02

4.  Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter.

Authors:  Leon M van den Toorn; Elsbeth Schaap; Veerle F M Surmont; Ellen M Pouw; Karin C D van der Rijt; Rob J van Klaveren
Journal:  Lung Cancer       Date:  2005-10       Impact factor: 5.705

Review 5.  Malignant pleural effusions.

Authors:  Joe B Putnam
Journal:  Surg Clin North Am       Date:  2002-08       Impact factor: 2.741

6.  Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.

Authors:  Helen E Davies; Eleanor K Mishra; Brennan C Kahan; John M Wrightson; Andrew E Stanton; Anur Guhan; Christopher W H Davies; Jamal Grayez; Richard Harrison; Anjani Prasad; Nicola Crosthwaite; Y C Gary Lee; Robert J O Davies; Robert F Miller; Najib M Rahman
Journal:  JAMA       Date:  2012-06-13       Impact factor: 56.272

7.  Treatment of malignant pleural effusions with tunneled long-term drainage catheters.

Authors:  J S Pollak; C M Burdge; M Rosenblatt; J P Houston; W J Hwu; J Murren
Journal:  J Vasc Interv Radiol       Date:  2001-02       Impact factor: 3.464

8.  Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion.

Authors:  William H Warren; Anthony W Kim; Michael J Liptay
Journal:  Eur J Cardiothorac Surg       Date:  2007-11-05       Impact factor: 4.191

Review 9.  [Surgical therapy for malignant pleural effusions].

Authors:  C Ludwig; E Stoelben
Journal:  Zentralbl Chir       Date:  2008-06       Impact factor: 0.942

10.  Pleural effusion in breast carcinoma: analysis of 122 cases.

Authors:  R N Raju; C G Kardinal
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.